4//SEC Filing
Fairmount Healthcare Fund II L.P. 4
Accession 0001104659-25-055989
CIK 0000907654other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 4:30 PM ET
Size
13.7 KB
Accession
0001104659-25-055989
Insider Transaction Report
Form 4
Kiselak Tomas
Director10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2025-06-02+17,500→ 17,500 total(indirect: By: Peter Harwin)Exercise: $11.77Exp: 2035-06-01→ Common Stock (17,500 underlying)
Fairmount Funds Management LLC
Director10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2025-06-02+17,500→ 17,500 total(indirect: By: Peter Harwin)Exercise: $11.77Exp: 2035-06-01→ Common Stock (17,500 underlying)
Fairmount Healthcare Fund II L.P.
Director10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2025-06-02+17,500→ 17,500 total(indirect: By: Peter Harwin)Exercise: $11.77Exp: 2035-06-01→ Common Stock (17,500 underlying)
Harwin Peter Evan
Director10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2025-06-02+17,500→ 17,500 total(indirect: By: Peter Harwin)Exercise: $11.77Exp: 2035-06-01→ Common Stock (17,500 underlying)
Fairmount Healthcare Co-Invest III L.P.
Director10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2025-06-02+17,500→ 17,500 total(indirect: By: Peter Harwin)Exercise: $11.77Exp: 2035-06-01→ Common Stock (17,500 underlying)
Footnotes (2)
- [F1]This option represents a right to purchase 17,500 shares of the Issuer's common stock, which vests as to 1/12 of the option monthly from June 2, 2025, subject to the recipient's continued service to the Issuer.
- [F2]Under Mr. Harwin's arrangement with Fairmount Funds Management LLC ("Fairmount"), Mr. Harwin holds the option for one or more investment vehicles managed by Fairmount (each, a "Fairmount Fund"). Mr. Harwin is obligated to turn over to Fairmount any net cash or stock received from the option for the benefit of such Fairmount Fund. Mr. Harwin therefore disclaims beneficial ownership of the option and underlying common stock. Fairmount disclaims beneficial ownership of any of the reported securities, except to the extent of its pecuniary interest therein.
Documents
Issuer
Oruka Therapeutics, Inc.
CIK 0000907654
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001769651
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 4:30 PM ET
- Size
- 13.7 KB